CBT
ONC

Capital Bank & Trust’s BeOne Medicines Ltd ONC Stock Holding History

Capital Bank & Trust’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-665
Closed -$241K – 11
2021
Q3 		$241K Sell
665
-164,299
-100% -$53.7M 8.15% 6
2021
Q2 		$56.6M Buy
164,964
+902
+0.5% +$299K 0.66% 56
2021
Q1 		$57.1M Buy
164,062
+2,073
+1% +$686K 0.68% 46
2020
Q4 		$41.9M Buy
161,989
+2,944
+2% +$811K 0.51% 58
2020
Q3 		$45.6M Buy
159,045
+1,129
+0.7% +$265K 0.61% 48
2020
Q2 		$29.8M Sell
157,916
-1,871
-1% -$305K 0.43% 66
2020
Q1 		$19.7M Sell
159,787
-3,758
-2% -$588K 0.33% 76
2019
Q4 		$27.1M Buy
163,545
+4,187
+3% +$696K 0.35% 79
2019
Q3 		$19.5M Sell
159,358
-21,376
-12% -$2.84M 0.27% 86
2019
Q2 		$22.4M Buy
180,734
+6,333
+4% +$804K 0.28% 87
2019
Q1 		$22.9M Buy
174,401
+113,401
+186% +$15.3M 0.29% 84
2018
Q4 		$8.56M Buy
+61,000
New +$8.09M 0.12% 113

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Capital Bank & Trust's ONC Position: Q4 2021 in Review

Capital Bank & Trust sold out of BeOne Medicines Ltd (ONC) in Q4 2021, closing a stake of 665 shares — an estimated $241K sold.

Capital Bank & Trust first reported a position in ONC in Q4 2018 and held it in 12 quarters. The position peaked at $57.1M in Q1 2021. 263 funds tracked by Wall St. Rank hold ONC as of Q4 2021.

  • Capital Bank & Trust reported no remaining BeOne Medicines Ltd position as of Q4 2021 after selling out during the quarter.
  • Capital Bank & Trust sold 665 BeOne Medicines Ltd shares in Q4 2021, an estimated $241K.
  • Capital Bank & Trust first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 12 quarters.
  • Capital Bank & Trust's BeOne Medicines Ltd position peaked at $57.1M in Q1 2021.
  • 263 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2021.

Based on Capital Bank & Trust's 13F filing for Q4 2021, filed 14 Feb 2022.